C. Hudson

发表

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

Jeffrey C. Erlich, S J Kish, S. Kish, 1997, Archives of general psychiatry.

No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis.

J. Lieberman, H. Meltzer, J. Kennedy, 1996, American journal of medical genetics.

Depression treatment by withdrawal of short-term low-dose antipsychotic, a proof-of-concept randomized double-blind study.

S. Kennedy, P. Seeman, P. Giacobbe, 2014, Journal of affective disorders.

Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia

B. Ross, C. Hudson, J. Warsh, 1999, Biological Psychiatry.

Genetic polymorphism data support a relationship between schizophrenia and microsatellite variability in PLA2G4A in Northern Europeans not Han Chinese

F. Macciardi, C. Hudson, R. Hudson, 2021, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Re-analysis of genetic polymorphism data supports a relationship between schizophrenia and microsatellite variability in PLA2G4A

C. Hudson, A. Durocher, J. Zhu, 2021, Psychiatric genetics.

Parkinson's Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response

P. Seeman, C. Hudson, M. Seeman, 2014, Parkinson's disease.

Possible relevance of phospholipid abnormalities and genetic interactions in psychiatric disorders: the relationship between dyslexia and schizophrenia.

D. Horrobin, C. Hudson, A. Glen, 1995, Medical hypotheses.

Genetic variant near cytosolic phospholipase A2 associated with schizophrenia

H. Meltzer, D. Horrobin, J. Kennedy, 1996, Schizophrenia Research.

CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia

C. Hudson, J. Warsh, L. Young, 1993, Synapse.

The niacin challenge test: Clinical manifestation of altered transmembrane signal transduction in schizophrenia?

C. Hudson, J. Warsh, F. Cashman, 1997, Biological Psychiatry.

Cytosolic phospholipase A2 gene in schizophrenia.

C. Hudson, 1999, The British journal of psychiatry : the journal of mental science.

Phospholipases: in search of a genetic base of schizophrenia.

D. Horrobin, C. Hudson, A. Lin, 1996, Prostaglandins, leukotrienes, and essential fatty acids.

Clinical detection of altered prostaglandin function in a schizophrenia subtype

C. Hudson, J. Warsh, A. Lin, 1995, Schizophrenia Research.

The niacin challenge test in schizophrenia: past, present and future.

C. Hudson, A. Lin, 1996, Prostaglandins, leukotrienes, and essential fatty acids.